🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximum tolerated dose and sa...
Status
Unknown
Location
Zhenzhou-Yang
Start Date
2014-11
Trial ID
NCT02277158
Treatments Being Tested
This is a Single arm, Simon's two stage pilot study in which patients with ...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2024-12-16
Trial ID
NCT06576635
Treatments Being Tested
In patients with unresectable perihilar cholangiocarcinoma, photodynamic th...
Status
Completed
Location
Asan Medical Center
Start Date
2009-02
Trial ID
NCT00869635
Treatments Being Tested
A Drug-Drug Interaction Study to Evaluate the Effect of Smoking (CYP1A2 Ind...
Status
Recruiting
Location
The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)
Start Date
2026-05-20
Trial ID
NCT07534176
Treatments Being Tested
A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2307....
Status
Completed
Location
Sites in germany
Start Date
2004-04
Trial ID
NCT00170976
Treatments Being Tested
This study study aims to elucidate the immune responses to a shared antigen...
Status
Completed
Location
Washington University School of Medicine
Start Date
2018-09-14
Trial ID
NCT03532217
This study will explore the efficacy and safety of tislelizumab (PD1 inhibi...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05350917
Treatments Being Tested
This is a phase 1, first in human, randomized, double-blind, placebo-contro...
Status
Completed
Location
Frontage Clinical Research Center
Start Date
2023-04-17
Trial ID
NCT05724797
The goal of this study is determine the safety and tolerability of orally t...
Status
Recruiting
Location
Sarah Cannon Research Institute
Start Date
2025-08-01
Trial ID
NCT06398418
Treatments Being Tested
The prevalence of peripheral arterial disease (PAD) and the proportion of e...
Status
Completed
Location
Zentralklinik Bad Berka GmbH
Start Date
2018-05-01
Trial ID
NCT03098290
Treatments Being Tested